Time to Confirmatory Study Initiation After Accelerated Approval of Cancer and Noncancer Drugs in the US

JAMA Intern Med. 2023 Jul 1;183(7):737-739. doi: 10.1001/jamainternmed.2023.0777.
No abstract available

Plain language summary

This cross-sectional study examines and compares the time taken from the accelerated approval of cancer and noncancer drugs to the initiation of confirmatory studies in the US.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Drug Approval
  • Humans
  • Neoplasms* / drug therapy
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents